"Understanding Failure to Thrive: Causes, Symptoms, and Interventions"

ruba82851 104 views 21 slides Aug 17, 2024
Slide 1
Slide 1 of 21
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21

About This Presentation

Failure to thrive is a medical condition in which an infant or child does not gain weight or grow as expected, often due to inadequate nutrition, underlying health issues, or environmental factors. It can indicate a range of potential problems requiring medical evaluation and intervention.


Slide Content

Failure to thrive: Cystic Fibrosis By Rubab imran

INTRODUCTION Since ancient times, children around the world have been afflicted with cystic fibrosis which leads to shortened lifespans. Salty skin was a sign of an impending illness without cause or cure. High salt levels in the sweat of patients with cystic fibrosis suggest an abnormality in electrolyte transport from the sweat glands. It is a chronic disease that frequently leads to chronic Sinopulmonary infections and pancreatic insufficiency The most common cause of death is end-stage lung disease

Definition Cystic fibrosis is an autosomal recessive genetic disorder with features that reflect mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene which encodes a protein expressed in the apical membrane of exocrine epithelial cells.

Epidermiology The most common mutation is delta F508, which is found in 70% of American white patients with CF and two-thirds of all cases worldwide. The mutation is a class 2 mutation of abnormal folding of the CFTR protein, leading to premature destruction within the Golgi apparatus. The delta F508 mutation commonly leads to exocrine pancreatic insufficiency and a higher likelihood of meconium ileus.

Pathophysiology CFTR transports chloride ions across cell membranes in the lungs, liver, pancreas, digestive tract, reproductive tract, and skin.

Sinus disease Occur when secretion viscosity increases which obstructs the sinus ostia. Ciliary dysfunction, increased inflammatory mediators, and increased bacterial colonization with pathogens like Pseudomonas aeruginosa. Subsequently, chronic sinusitis occurs, and secondary structural damage may occur.

Lung disease A high rate of sodium absorption and low rate of chloride secretion reduces salt and water content in mucus and depletes peri-ciliary liquid. The mucus adheres to the airway surface, leading to decreased mucus clearing. Predisposition to Staph and Pseudomonas infection. Bronchiectasis and further thick purulent sputum production occur. Poorly managed pulmonary manifestations are the primary cause of death in patients with CF.

Pancreatic manifestation Obstruction of the pancreatic ductules by thickened secretions. As a result, intestinal chyme is not enzymatically processed in the intestines resulting in pathognomonic greasy stools, colicky abdominal pain, and malabsorption of nutrients from food. Specifically, fat-soluble vitamins A, D, E, and K are notably deficient.

Cont.. Auto-digestion of the pancreas may occur as this enzyme targets the pancreatic tissues. In severe, chronic cases, this can lead to endocrine pancreatic failure when the islets of Langerhans begin to be digested by trapped pancreatic enzymes. The lasting impacts of this spectrum of disease mimic type-1 Diabetes Mellitus.

Biliary and hepatic systems The biliary ductules may be plugged with secretion. Obstructive cirrhosis and post-hepatic hyperbilirubinemia can occur. Gallbladder disease is more likely to occur as a spectrum of this manifestation of CF, with up to 15% of those with cystic fibrosis having gallstones.

Sweat glands Normally sweat glands move chloride from the extracellular space into the intracellular space. Thus, sodium and water are reabsorbed from the sweat gland tissue into the body. However, failure of the chloride channel to reabsorb chloride leads to a loss of sodium onto the skin surface and a subsequent fluid loss. This causes the pathognomonic salty skin seen with cystic fibrosis.

History and Physical Newborns with CF may present with meconium ileus, prolonged neonatal jaundice, or early lung infection. Infants and children with CF may present with failure to thrive and poor weight gain, anemia, undescended testicles in boys, recurrent sinopulmonary infections, and a distal intestinal obstructive syndrome with or without pancreatic insufficiency.

C ont.… Males may be infertile due to absent vas deferens. Females have reduced fertility due to thickened cervical mucus.

Investigation The diagnostic pathway starts with a sweat chloride test. If normal but still symptomatic, a repeat sweat chloride test is indicated. If the test is abnormal, DNA testing is indicated. If one or less CFTR mutations are found, expanded DNA analysis is indicated. However, the finding of 2 CF-related mutations confirms the diagnosis of cystic fibrosis.

Cont.. The test for immunoreactive trypsinogen (IRT), a pancreatic enzyme, increases sensitivity and specificity in screening newborns with meconium ileus for CF.

Additional Dignostic A chest radiography may help identify hyperinflation, bronchiectasis, and abscesses. Sinus radiography may demonstrate panopacification of the paranasal sinuses. Abdominal radiography may be helpful in neonatal who present with meconium ileus Bronchoalveolar lavage typically shows many neutrophils

Differential diagnosis Asthma Bronchiolitis Bronchiectasis Nutritional considerations in failure to thrive Pediatric aspergillosis Primary ciliary dyskinesia Sinusitis

Treatment Cystic fibrosis is a systemic that has broad implications for both quality and quantity of life when poorly controlled. Therefore, treatment should focus on optimizing function to avoid acute illness events. CF guidelines recommend at least one antibiotic to cover each pathogenic bacteria cultured from respiratory secretions and two antibiotics for P.aeruginosa infections.

Cont. Ventilation and oxygenation should be supported through the use of inhaled bronchodilators, including albuterol and ipratropium bromide. Agents such as inhaled dornase Alfa or inhaled hypertonic saline are prescribed to promote airway secretion clearance in conjunction with chest physiotherapy. Anti-inflammatory medicines such as glucocorticoids are also used to assist in opening airways to relieve the obstruction.

Thank you